Oppenheimer Asset Management Inc. Purchases 144 Shares of Chemed Co. (NYSE:CHE)

Oppenheimer Asset Management Inc. lifted its position in Chemed Co. (NYSE:CHE) by 24.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 722 shares of the company’s stock after purchasing an additional 144 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Chemed were worth $392,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of CHE. Principal Securities Inc. bought a new stake in Chemed during the fourth quarter valued at about $51,000. Norges Bank bought a new stake in Chemed during the 4th quarter valued at approximately $92,359,000. Corient Private Wealth LLC lifted its holdings in Chemed by 7.9% in the 4th quarter. Corient Private Wealth LLC now owns 2,741 shares of the company’s stock worth $1,603,000 after purchasing an additional 200 shares in the last quarter. Trexquant Investment LP bought a new position in Chemed in the 4th quarter worth approximately $3,254,000. Finally, Franklin Resources Inc. boosted its stake in Chemed by 45.4% in the 4th quarter. Franklin Resources Inc. now owns 9,861 shares of the company’s stock worth $5,766,000 after purchasing an additional 3,077 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $569.63, for a total transaction of $1,139,260.00. Following the sale, the chief executive officer now directly owns 105,735 shares of the company’s stock, valued at $60,229,828.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the completion of the transaction, the executive vice president now owns 6,109 shares in the company, valued at approximately $3,478,159.15. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the completion of the sale, the chief executive officer now owns 105,735 shares in the company, valued at approximately $60,229,828.05. The disclosure for this sale can be found here. Insiders have sold a total of 6,744 shares of company stock valued at $3,828,231 in the last quarter. 3.32% of the stock is currently owned by insiders.

Chemed Price Performance

Chemed stock opened at $582.06 on Friday. The firm’s 50 day moving average price is $569.34 and its 200-day moving average price is $577.64. Chemed Co. has a 1 year low of $497.36 and a 1 year high of $654.62. The stock has a market cap of $8.81 billion, a P/E ratio of 31.33, a PEG ratio of 2.31 and a beta of 0.44.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. During the same quarter in the previous year, the firm earned $4.71 EPS. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, equities analysts expect that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date was Monday, August 12th. This is a boost from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio (DPR) is currently 10.76%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.